Who is sponsoring NCT04512794?

NCT04512794 is sponsored by Acutus Medical.

What drugs are being tested in NCT04512794?

Interventions in NCT04512794: AcQMap High Resolution Imaging and Mapping System.

What condition does NCT04512794 study?

NCT04512794 studies Atrial Arrhythmias.

Is NCT04512794 still recruiting?

NCT04512794 is currently withdrawn. Last updated 22 March 2022.

Last reviewed 2022-03-22 · How we verify

NCT04512794: PLASZMA

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Pulmonary Vein Isolation Plus Left Atrial Slow Zone Mapping and Ablation

Withdrawn NA Last updated 22 March 2022

What this trial tests

NA trial testing AcQMap High Resolution Imaging and Mapping System in Atrial Arrhythmias. Withdrawn.

Timeline

1 September 2022

Primary endpoint
1 September 2023

1 December 2023

Quick facts

Lead sponsor	Acutus Medical
Phase	NA
Status	Withdrawn
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	diagnostic
Start date	1 September 2022
Primary completion	1 September 2023
Estimated completion	1 December 2023

Drugs / interventions tested

AcQMap High Resolution Imaging and Mapping System

Conditions studied

Atrial Arrhythmias — all drugs for Atrial Arrhythmias →

Sponsor

Acutus Medical

Who can join

Adults 18 to 80, any sex, with Atrial Arrhythmias. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Pulmonary Vein Isolation Plus Left Atrial Slow Zone Mapping and Ablation: An AcQMap Substrate Characterization Study (PLASZMA)

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Atrial Arrhythmias

Currently open trials in the same condition.

NCT06847932 — Leveraging AI-ECG Technology for Early Notification and Tracking of AF Development · NA · recruiting
NCT06452589 — The Field PULSE Study · NA · recruiting

Other Acutus Medical trials

Trials by the same sponsor.

NCT04904354 — AcQBlate Force Sensing Ablation System US IDE Study for Atrial Fibrillation · NA · withdrawn
NCT05181878 — AcQMap 2.1 With Electro-Magnetic Tracking System Feasibility Study (EMT Feasibility Study) · completed
NCT05113056 — AcQForce Pulsed Field Ablation-CE · NA · completed
NCT04658940 — AcQBlate Force Sensing Ablation System US IDE for Atrial Flutter (AcQForce Flutter) · NA · completed
NCT04429464 — AcQBlate Force Confirmatory Study for Atrial Arrhythmias · NA · withdrawn

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04512794 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Acutus Medical
Last refreshed: 22 March 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04512794.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing